James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 856,560 shares at $1.79 ($2.1M) on 2022-04-04, disclosed to the SEC on 2022-04-22.
Open-market sale of $2.1M CKPT by CEO, President and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.11 | 302,777 | $942K | 45.6% |
| 2 | $2.77 | 53,024 | $147K | 7.1% |
| 3 | $2.19 | 143,136 | $313K | 15.2% |
| 4 | $2.46 | 31,972 | $79K | 3.8% |
| 5 | $1.85 | 117,657 | $218K | 10.5% |
| 6 | $1.79 | 86,353 |
| $155K |
| 7.5% |
| 7 | $1.79 | 86,353 | $155K | 7.5% |
| 8 | $1.77 | 14,030 | $25K | 1.2% |
| 9 | $1.51 | 21,258 | $32K | 1.6% |
| Total | $2.41 avg | 856,560 | $2.1M | 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |